GSK1904529A
| Supplier | MedChemExpress |
|---|---|
| Product # | HY-10524-50 mg |
| CAS # | 1089283-49-7 |
| Pricing | 50 mg, USD $345.0 |
| Biological Activity | GSK1904529A is a potent, selective, orally active, and ATP-competitive inhibitor of insulin-like growth factor-1 receptor (IGF-1R) and insulin receptor (IR), with IC50s of 27 and 25 nM, respectively. GSK1904529A shows poor activity (IC50>1 μM) in 45 other serine/threonine and tyrosine kinases. GSK1904529A exhibits anti-tumor activity[1][2]. |
| Purity | 99.22% |
| MWt | 851.96 |
| Formula | C₄₄H₄₇F₂N₉O₅S |